TY  - GEN 
AU  - Maza-Solano, J.
AU  - Calvo Henríquez, Christian Ezequiel
AU  - Alobid, I.
AU  - Álvarez-Cendrero, M.
AU  - Palomares, Ó.
AU  - Moreno-Luna, R.
AU  - Santos-Perez, J.
AU  - González-García, J.
AU  - Sánchez-Gómez, S.
PY  - 2022
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.11940/20753
AB  - Currently, some monoclonal antibodies (mAbs) are being studied for chronic rhinosinusitis with nasal polyps (CRSwNP). Three anti-IL-5 mAb: mepolizumab, reslizumab and benralizumab, have been tested through randomized clinical trials. In this real-life...
LA  - eng
TI  - Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study
DO  - 10.3390/jcm11237056
KW  - AS Santiago
KW  - CHUS
KW  - IDIS
VL  - 11
ER  -